Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline.
Focus-X Therapeutics's investors include Viva BioInnovator, Xiamen Changrong Investment Management.
Focus-X Therapeutics is headquartered in Sammamish, United States.
Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline.
Focus-X Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Focus-X Therapeutics — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/focus-x-therapeutics. Accessed August 24, 2026.
VCBacked. (2022). Focus-X Therapeutics — Funding & Investors. Retrieved August 24, 2026, from https://www.vcbacked.co/company/focus-x-therapeutics
{{cite web |title=Focus-X Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/focus-x-therapeutics |website=VCBacked |access-date=August 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated